YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$12.28 USD
-0.59 (-4.58%)
Updated May 10, 2024 04:00 PM ET
After-Market: $12.27 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.10 | 3.22% |
Earnings Summary
For their last quarter, YmAbs Therapeutics (YMAB) reported earnings of -$0.15 per share, missing the Zacks Consensus Estimate of -$0.12 per share. This reflects a negative earnings surprise of 25.00%. Look out for YMAB's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 28.57%.
Earnings History
Price & Consensus
Zacks News for YMAB
New Strong Buy Stocks for April 19th
YMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services